Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Operating Activities:    
Net Loss $ (2,302,766) $ (2,111,470)
Adjustments to reconcile net loss from operations to net cash used in operating activities:    
Stock based compensation 210,653 628,445
Depreciation and amortization 12,390 14,517
Unrealized (Gains) losses on marketable securities 46,001 (109,757)
Changes in non-cash operating working capital items:    
Accounts receivable - fees and reimburseable project costs (61,426) (387,179)
Prepaid expenses and other assets 52,845 (244,885)
Accounts payable, accrued liabilities and other current liabilities 37,719 (750,108)
Net Cash Used In Operating Activities (2,004,584) (2,960,437)
Investing Activities:    
Proceeds from the sale of marketable securities 500,000 397,926
Purchase of marketable securities (32,831) (121,173)
Patent costs (73,354) (38,956)
Property and equipment 0 (19,738)
Net Cash Provided By Investing Activities 393,815 218,059
Financing Activities:    
Proceeds from the issuance of common stock 0 1,733
Restricted cash (770) (967)
Net Cash Provided By (Used In) Financing Activities (770) 766
Net Decrease In Cash and Cash Equivalents (1,611,539) (2,741,612)
Cash and Cash Equivalents, Beginning of Period 2,197,555 3,569,098
Cash and Cash Equivalents, End of Period 586,016 827,486
Cash paid during the year:    
Interest paid 0 0
Income taxes paid $ 0 $ 0